CFTR and cystic fibrosis: To further validate our model of short-term CFTR inhibition, we sought to characterise the phenotype created following CFTR inhibition and to compare this directly with a transgenic CF mouse model (ΔF508)39, a CFTR KO model40 and the known literature on CF disease.